Cancer Outcomes and Services Diagram
 

Click on the items in the diagram to open definitions on the right.

Description of ABNORMALITY IDENTIFIER Description of CYTOLOGICAL ABNORMALITY Description of DEATH CAUSE COMMENT Description of DEATH CAUSE Description of CELL PATHOLOGICAL ABNORMALITY Description of PERSON DEATH DATE Description of DEATH CAUSE IDENTIFICATION METHOD Description of DEATH LOCATION TYPE CODE Description of PERSON DEATH DETAILS Description of ABLATIVE THERAPY TYPE Description of ADDITIONAL UNPLANNED PROCEDURE REQUIRED INDICATOR Description of ADJUNCTIVE THERAPY TYPE Description of ASA PHYSICAL STATUS CLASSIFICATION SYSTEM CODE Description of BIOPSY TYPE FOR CENTRAL NERVOUS SYSTEM TUMOURS Description of BRACHYTHERAPY TYPE Description of CANCER IMAGING MODALITY Description of CANCER IMAGING OUTCOME Description of CANCER TREATMENT MODALITY Description of CARDIOPULMONARY EXERCISE TEST TYPE Description of CLINICAL INTERVENTION TEXT STRING Description of DIEPOXYBUTANE TEST RESULT Description of DRUG TREATMENT INTENT Description of ENDOSCOPIC OR RADIOLOGICAL COMPLICATION TYPE Description of ENDOSCOPIC PROCEDURE TYPE Description of EXCISION TYPE FOR CENTRAL NERVOUS SYSTEM TUMOURS Description of GERMLINE GENETIC TEST TYPE OFFERED Description of IMAGING ANATOMICAL SITE Description of LIVER SURGERY PERFORMED TYPE Description of LIVER TRANSARTERIAL EMBOLISATION OF HEPATOCELLULAR CARCINOMA INDICATOR Description of MARGIN INVOLVED INDICATION CODE Description of NEOADJUVANT THERAPY INDICATOR Description of PATIENT PROCEDURE PERFORMED INDICATOR Description of PATIENT TREATED TO CHILDRENS CANCER AND LEUKAEMIA GROUP GUIDELINES INDICATOR Description of PLANE OF SURGICAL EXCISION TYPE Description of PRETREATMENT PROSTATE BIOPSY TECHNIQUE TYPE Description of PRIMARY INDUCTION CHEMOTHERAPY FAILURE INDICATOR Description of PRINCIPAL DIAGNOSTIC IMAGING TYPE Description of PROSTATE NERVE SPARING SURGERY TYPE Description of RADICAL PROSTATECTOMY MARGIN STATUS Description of RADIOTHERAPY PRESCRIBED DOSE Description of RADIOTHERAPY TREATMENT MODALITY Description of REGIONAL ANAESTHETIC TECHNIQUE FOR CANCER Description of RELAPSE METHOD DETECTION TYPE Description of SARCOMA SURGICAL MARGIN Description of STEM CELL INFUSION SOURCE CODE Description of STEM CELL TRANSPLANT CONDITIONING REGIMEN Description of SURGICAL ACCESS TYPE Description of SURGICAL COMPLICATION TYPE Description of SURGICAL PALLIATION TYPE Description of CLINICAL INTERVENTION Description of CATEGORY VALUED PERSON OBSERVATION Description of ANATOMICAL SIDE FOR IMAGING Description of HYDRONEPHROSIS CODE Description of PRIMARY EXTRANODAL SITE Description of PERSON PROPERTY QUALIFIER Description of ACTIVITY Description of CANCER OR SYMPTOMATIC BREAST REFERRAL PATIENT STATUS Description of CANCER TREATMENT INTENT Description of CHILDREN TEENAGERS AND YOUNG ADULTS AGE CATEGORY Description of HOLISTIC NEEDS ASSESSMENT POINT OF PATHWAY FOR CANCER Description of MONITORING INTENT Description of PALLIATIVE CARE SPECIALIST SEEN INDICATOR Description of PALLIATIVE TREATMENT REASON CODE FOR UPPER GASTROINTESTINAL Description of ACTIVITY GROUP Description of ADULT COMORBIDITY EVALUATION 27 SCORE Description of EUROPEAN GROUP FOR THE IMMUNOLOGICAL CLASSIFICATION OF LEUKAEMIA SCORING SYSTEM SCORE Description of PERSON SCORE Description of PERSON SCORE Description of MULTIDISCIPLINARY TEAM MEETING TYPE FOR CANCER Description of NO CANCER TREATMENT REASON Description of CARE PLAN Description of AMERICAN JOINT COMMITTEE ON CANCER STAGE Description of ANN ARBOR BULKY DISEASE INDICATION CODE Description of ANN ARBOR EXTRANODALITY INDICATION CODE Description of ANN ARBOR SPLENIC INDICATION CODE Description of ANN ARBOR STAGE Description of ANN ARBOR SYMPTOMS INDICATION CODE Description of BARCELONA CLINIC LIVER CANCER STAGE Description of BINET STAGE Description of BREAST INVASIVE GRADE Description of CERVICAL INTRAEPITHELIAL NEOPLASIA PRESENCE AND GRADE Description of CHANG STAGING SYSTEM STAGE Description of CLINICAL STAGE FOR PANCREATIC CANCER Description of DUCTAL CARCINOMA IN SITU GRADE Description of FRENCH AMERICAN BRITISH CLASSIFICATION FOR ACUTE MYELOID LEUKAEMIA Description of GLEASON GRADE Description of INTERGROUP RHABDOMYOSARCOMA STUDY POST SURGICAL GROUP Description of INTERNATIONAL CLASSIFICATION FOR INTRAOCULAR RETINOBLASTOMA Description of INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS STAGE Description of INTERNATIONAL NEUROBLASTOMA RISK GROUP STAGING SYSTEM STAGE Description of INTERNATIONAL STAGING SYSTEM STAGE FOR RETINOBLASTOMA Description of MODIFIED DUKES STAGE Description of MURPHY ST JUDE STAGE Description of MYELOMA INTERNATIONAL STAGING SYSTEM STAGE Description of PRETEXT STAGING SYSTEM STAGE Description of PRETEXT STAGING SYSTEM STAGE OUTSIDE LIVER Description of STAGE GROUPING FOR TESTICULAR CANCER Description of TNM CATEGORY Description of TNM CODING EDITION Description of TNM VERSION NUMBER Description of WILMS TUMOUR STAGE Description of CANCER STAGING Description of PERSON ORGAN Description of DECISION TO TREAT DATE Description of PLANNED CANCER TREATMENT TYPE Description of PLANNED ACTIVITY Description of PERSON PROPERTY Description of NHS NUMBER Description of PATIENT Description of ACUTE MYELOID LEUKAEMIA RISK FACTORS Description of ALK 1 STATUS Description of CERVICAL GLANDULAR INTRAEPITHELIAL NEOPLASIA PRESENCE AND GRADE Description of CERVICAL NODE STATUS Description of CLINICAL ASSESSMENT RESULT CODE FOR BREAST CANCER Description of CLINICAL INVESTIGATION RESULT ANALYSED DATE Description of CYTOGENETIC ABNORMALITY RISK GROUP Description of CYTOGENETIC ANALYSIS CODE Description of CYTOGENETIC PRESENCE TYPE FOR RHABDOMYOSARCOMA Description of CYTOGENETIC RISK CODE Description of CYTOGENETIC RISK GROUP FOR PAEDIATRIC MOLECULAR GENETIC ABNORMALITIES Description of D29 BONE MARROW TEST RESULT Description of DETRUSOR MUSCLE PRESENCE INDICATION CODE Description of EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONAL STATUS Description of EXCISION MARGIN INDICATION CODE Description of GENETIC CONFIRMATION INDICATOR Description of GRADE OF DIFFERENTIATION Description of GRADE OF DIFFERENTIATION FOR COLORECTAL Description of HEPATOMEGALY INDICATOR Description of HORMONE EXPRESSION TYPE Description of KARYOTYPE TEST OUTCOME Description of LACTATE DEHYDROGENASE LEVEL Description of METASTASIS EXTENT CODE Description of PAEDIATRIC MYELODYSPLASIA CLINICAL FINDINGS Description of PATHOLOGICAL RISK CLASSIFICATION CODE AFTER NEPHRECTOMY Description of PATHOLOGICAL RISK CLASSIFICATION CODE AFTER PREOPERATIVE CHEMOTHERAPY Description of PREOPERATIVE THERAPY RESPONSE TYPE Description of RISK GROUP ALLOCATION FOR ACUTE LYMPHOBLASTIC LEUKAEMIA Description of SENTINEL LYMPH NODE BIOPSY OUTCOME Description of SPECIMEN NATURE Description of SPLEEN BELOW COSTAL MARGIN Description of SPLENOMEGALY INDICATOR Description of S CATEGORY CODE Description of TUMOUR NECROSIS Description of VISUAL ACUITY OR FIELD TEST RESULT Description of CLINICAL INVESTIGATION RESULT ITEM Description of ANAPLASTIC NEPHROBLASTOMA TYPE Description of BONE INVASION INDICATION CODE Description of CANCER RECURRENCE OR METASTATIC DISEASE TYPE Description of CAPSULE STATUS Description of CARTILAGE INVASION INDICATION CODE Description of CLARKS LEVEL IV INDICATION CODE Description of CORE BIOPSY RESULT CODE FOR BREAST Description of CORE BIOPSY RESULT CODE FOR NODE Description of CYTOLOGY RESULT CODE Description of D29 STATUS OF EXTRAMEDULLARY DISEASE Description of DYSPLASTIC HAEMOPOIESIS TYPE Description of EXTENT OF ATELECTASIS Description of EXTENT OF METASTATIC SPREAD Description of EXTENT OF PLEURAL INVASION Description of EXTRACAPSULAR SPREAD INDICATION CODE Description of EXTRAMEDULLARY DISEASE SITE Description of EXTRANODAL SPREAD INDICATOR Description of GENE OR STRATIFICATION BIOMARKER TYPE ANALYSED Description of INTRALYMPHATIC METASTATIC CELLS SEPARATION INDICATOR Description of LARGEST METASTASIS Description of LESION GREATER THAN 20MM INDICATION CODE Description of LESION SIZE Description of LESION VERTICAL THICKNESS GREATER THAN 2MM INDICATION CODE Description of LUNG METASTASES SUB STAGE GROUPING Description of MACROSCOPIC EXTRAGLANDULAR EXTENSION INDICATION CODE Description of MALIGNANT PLEURAL EFFUSION INDICATOR Description of MAXIMUM DEPTH OF INVASION Description of METASTATIC SITE Description of METASTATIC STATUS Description of MICROSCOPIC INVOLVEMENT INDICATION CODE Description of MICROSCOPIC INVOLVEMENT INDICATOR Description of MIXED PHENOTYPE ACUTE LEUKAEMIA SYMPTOMS Description of MOLECULAR DIAGNOSTIC CODE Description of MULTIFOCAL OR SYNCHRONOUS TUMOUR INDICATOR Description of MULTIFOCAL TUMOUR INDICATOR FOR BREAST Description of MYOMETRIAL INVASION IDENTIFICATION CODE Description of NODAL STATUS Description of NUMBER OF ABNORMAL NODAL AREAS Description of NUMBER OF COLORECTAL METASTASES IN LIVER CODE Description of NUMBER OF EXTRANODAL SITES CODE Description of NUMBER OF LYMPHADENOPATHY AREAS Description of OMENTUM INVOLVEMENT INDICATION CODE Description of ORGAN CONFINED INDICATOR Description of OVARY SURFACE INVOLVEMENT INDICATOR Description of PARACERVICAL OR PARAMETRIAL INVOLVEMENT INDICATOR Description of PERINEURAL INVASION INDICATOR Description of PERITONEAL CYTOLOGY RESULT CODE Description of PERITONEAL INVOLVEMENT INDICATOR Description of PERITONEAL WASHINGS IDENTIFIED Description of PORTAL VEIN INVASION INDICATION CODE Description of POST OPERATIVE TUMOUR SITE FOR UPPER GASTROINTESTINAL Description of PRIMARY TUMOUR STATUS Description of RECEPTOR STATUS Description of RENAL VEIN TUMOUR INDICATOR Description of RESECTION MARGIN INVOLVEMENT INDICATOR Description of RESECTION STATUS Description of RESIDUAL DISEASE SIZE FOR GYNAECOLOGICAL CANCER Description of RETINOBLASTOMA ASSESSMENT LATERALITY Description of RHABDOMYOSARCOMA SITE PROGNOSIS CODE Description of SARCOMA TUMOUR SUBSITE FOR BONE Description of SARCOMA TUMOUR SUBSITE FOR SOFT TISSUE Description of SATELLITE TUMOUR NODULES LOCATION Description of SKIN CANCER LESION NUMBER Description of SMILE INDICATION CODE Description of SYNCHRONOUS TUMOUR COLON LOCATION Description of SYNCHRONOUS TUMOUR INDICATOR Description of TUMOUR BREACH IDENTIFIER Description of TUMOUR DEPTH Description of TUMOUR GRADE FOR UROLOGY Description of TUMOUR INFILTRATING LYMPHOCYTE TYPE Description of TUMOUR INVASION INDICATOR Description of TUMOUR LOCAL STAGE Description of TUMOUR NECROSIS Description of TUMOUR NECROSIS INDICATOR Description of TUMOUR OR LESION LATERALITY Description of TUMOUR OR LESION LOCATION Description of TUMOUR PROXIMITY TO CARINA Description of TUMOUR REGRESSION INDICATION CODE Description of TUMOUR RUPTURE INDICATOR Description of TUMOUR SIZE Description of TUMOUR VOLUME AT DIAGNOSIS CODE Description of ULCERATION INDICATION CODE Description of UNDERLYING DISEASE ASSOCIATED WITH MYELODYSPLASIA Description of VIABLE TUMOUR INDICATOR Description of MALIGNANT ABNORMALITY Description of TISSUE IDENTIFIER Description of TISSUE BANKED AT DIAGNOSIS INDICATOR Description of TISSUE TYPE BANKED AT DIAGNOSIS Description of TISSUE Description of CELL IDENTIFIER Description of CELL Description of LIFE THREATENING SYMPTOMS AT DIAGNOSIS INDICATOR Description of LIVER CIRRHOSIS CAUSE TYPE Description of LIVER CIRRHOSIS TYPE Description of OTHER MYELODYSPLASIA SYMPTOMS AT DIAGNOSIS Description of PRIMARY DIAGNOSIS Description of TUMOUR OR LESION LATERALITY Description of PATIENT DIAGNOSIS Description of PERSON IDENTIFIER Description of PERSON BIRTH DATE Description of PERSON Description of CARE PROFESSIONAL OPERATING SURGEON TYPE FOR CANCER Description of CARE PROFESSIONAL SENIOR OPERATING SURGEON GRADE FOR CANCER Description of CARE PROFESSIONAL Description of PERSON STATED GENDER CODE Description of PERSON STATED GENDER Description of ASSESSMENT TOOL TYPE Description of ASSESSMENT TOOL Description of CLINICAL NURSE SPECIALIST INDICATION CODE Description of CARE CONTACT Description of CARE ACTIVITY /
ISO 9001 CERTIFICATION EUROPE